Understanding Ovarian Cancer with Peritoneal Carcinomatosis: A Guide for Indian Women

Ovarian Cancer with Peritoneal Carcinomatosis: What You Need to Know Ovarian cancer is a significant health concern for women worldwide, and understanding its various forms is crucial for early detection and effective treatment. One such form is ovarian cancer with peritoneal carcinomatosis. This condition occurs when ovarian cancer spreads to the peritoneum, the thin tissue that lines the abdominal cavity and covers the abdominal organs. In India, where awareness about gynaecological cancers is growing, it's vital for women to be informed about this advanced stage of ovarian cancer. What is Peritoneal Carcinomatosis? The peritoneum is a serous membrane that forms a protective lining within the abdomen. It's like a delicate sac that holds and supports your abdominal organs, including the stomach, intestines, liver, and ovaries. When ovarian cancer cells break away from the primary tumour on the ovary, they can travel through the fluid within the abdominal cavity. These cells can then settle on the surface of the peritoneum and begin to grow, forming new tumours. This spread is known as peritoneal carcinomatosis. It's important to understand that peritoneal carcinomatosis is not a separate disease but rather a sign that ovarian cancer has advanced. It is commonly seen in Stage 3 or Stage 4 ovarian cancer, meaning the cancer has spread beyond the ovaries. Researchers estimate that in about 70% of advanced ovarian cancer cases, the cancer has spread to the peritoneum. Symptoms of Ovarian Cancer with Peritoneal Carcinomatosis The symptoms of ovarian cancer with peritoneal carcinomatosis can often be vague and may be mistaken for other common ailments, especially in the early stages. However, as the condition progresses and the peritoneum becomes involved, certain symptoms may become more pronounced: Abdominal Bloating and Swelling: This is a very common symptom, often due to a condition called ascites. Ascites is a buildup of fluid in the abdominal cavity, which can cause the belly to distend and feel tight. About 70% of people with peritoneal carcinomatosis experience ascites. Abdominal Pain or Pressure: Persistent pain or a feeling of fullness and pressure in the abdomen or pelvic region can be indicative of the growing tumours or fluid buildup. Changes in Bowel Habits: The pressure from tumours or fluid can affect the intestines, leading to constipation, diarrhoea, or a feeling of incomplete bowel movements. Unexplained Weight Loss: While some women may experience weight gain due to fluid retention, others might lose weight unintentionally due to loss of appetite or the cancer's metabolic effects. Changes in Menstrual Cycles: For premenopausal women, irregular periods or heavier bleeding might occur. Fatigue: Persistent tiredness and lack of energy are common in many types of cancer, including advanced ovarian cancer. Loss of Appetite: Feeling full quickly or having no desire to eat can be a symptom. It's crucial to remember that these symptoms can also be caused by less serious conditions. However, if you experience a combination of these, especially if they are persistent or worsening, it is essential to consult a doctor. Causes and Risk Factors Ovarian cancer itself arises from mutations in the DNA of ovarian cells, causing them to grow uncontrollably and form a tumour. The exact causes of ovarian cancer are not fully understood, but several risk factors have been identified: Age: The risk increases with age, particularly after menopause. Family History: A history of ovarian, breast, or colorectal cancer in the family can increase the risk. Genetic mutations like BRCA1 and BRCA2 are strongly linked. Endometriosis: This condition, where uterine tissue grows outside the uterus, is associated with an increased risk. Hormone Replacement Therapy (HRT): Some forms of HRT may increase the risk. Obesity: Being overweight or obese is linked to a higher risk of ovarian cancer. Never Having Been Pregnant: Women who have never had a full-term pregnancy may have a slightly higher risk. Peritoneal carcinomatosis specifically occurs when the cancer cells from the ovary metastasize (spread) to the peritoneum. This is more common in aggressive types of ovarian cancer or when the cancer is diagnosed at a later stage. Diagnosis Diagnosing ovarian cancer with peritoneal carcinomatosis involves a combination of methods: Medical History and Physical Examination: Your doctor will ask about your symptoms and medical history, and perform a pelvic exam. Imaging Tests: Ultrasound: Transvaginal or abdominal ultrasounds can help visualize the ovaries, uterus, and detect fluid in the abdomen. CT Scan (Computed Tomography): This provides detailed cross-sectional images of the abdomen and pelvis, helping to assess the extent of cancer spread, including to the peritoneum. MRI (Magnetic Resonance Imaging): MRI can offer more detailed images of soft tissues and is useful in staging the cancer. Blood Tests: A CA-125 blood test is often used. CA-125 is a protein that can be elevated in ovarian cancer, although it can also be raised in other conditions. It's more useful for monitoring treatment response and recurrence than for initial diagnosis. Biopsy: A biopsy is the definitive way to diagnose cancer. This might involve a laparoscopic procedure (keyhole surgery) to obtain tissue samples from the peritoneum or ascites fluid for examination under a microscope. The goal of these tests is to determine the type of ovarian cancer, its stage, and whether it has spread to the peritoneum or other parts of the body. Treatment Options Treatment for ovarian cancer with peritoneal carcinomatosis is typically aggressive and aims to remove as much cancer as possible and control its spread. The primary treatment modalities include: 1. Cytoreductive

In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.